Australia, May 3 -- Baxter International Inc., owns the trademark (2484641) for 'MYXREDLIN' till Sept. 23, 2034.
Status: registered:
Registered/protected
Class: 5 [pharmaceutical products, namely, pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; pharmaceutical preparations containing insulin]
Type of Mark: Word
Date of Acceptance: Nov. 1, 2024
Registration Advertised: May 2
For further details contact Maxwells Patent & Trade Mark Attorneys Pty. Ltd. .
The original document can be viewed at: https://search.ipaustralia.gov.au/trademarks/search/view/2484641.
Disclaimer: Curated by HT Syndication....